Literature DB >> 26503809

Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis.

J E Megías-Vericat1,2, L Rojas1,3, M J Herrero1,4, V Bosó1,2, P Montesinos5, F Moscardó5, J L Poveda2, M A Sanz5, S F Aliño1,4,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26503809     DOI： 10.1038/tpj.2015.79

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  7 in total

1.  Impact of ABCB1 single nucleotide polymorphisms 1236C>T and 2677G>T on overall survival in FLT3 wild-type de novo AML patients with normal karyotype.

Authors:  Ingrid Jakobsen Falk; Anna Fyrberg; Esbjörn Paul; Hareth Nahi; Monica Hermanson; Richard Rosenquist; Martin Höglund; Lars Palmqvist; Dick Stockelberg; Yuan Wei; Henrik Gréen; Kourosh Lotfi
Journal:  Br J Haematol       Date:  2014-08-23       Impact factor: 6.998

2.  MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis.

Authors:  Chrysoula Doxani; Michael Voulgarelis; Elias Zintzaras
Journal:  Biomarkers       Date:  2013-06-27       Impact factor: 2.658

3.  Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia.

Authors:  Hui He; Jiye Yin; Xi Li; Yu Zhang; Xiaojing Xu; Ming Zhai; Juan Chen; Chenyue Qian; Honghao Zhou; Zhaoqian Liu
Journal:  Eur J Clin Pharmacol       Date:  2015-01-09       Impact factor: 2.953

4.  Multidrug resistance-1 gene polymorphisms associated with treatment outcomes in de novo acute myeloid leukemia.

Authors:  Dong Hwan Kim; Jae Yong Park; Sang Kyun Sohn; Nan Young Lee; Jin Ho Baek; Seok Bong Jeon; Jong Gwang Kim; Jang Soo Suh; Young Rok Do; Kyu Bo Lee
Journal:  Int J Cancer       Date:  2006-05-01       Impact factor: 7.396

5.  Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: a systematic review and meta-analysis of observational studies.

Authors:  J E Megías-Vericat; L Rojas; M J Herrero; V Bosó; P Montesinos; F Moscardó; J L Poveda; M Á Sanz; S F Aliño
Journal:  Pharmacogenomics J       Date:  2015-01-06       Impact factor: 3.550

6.  Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype.

Authors:  H Gréen; I J Falk; K Lotfi; E Paul; M Hermansson; R Rosenquist; C Paul; H Nahi
Journal:  Pharmacogenomics J       Date:  2010-10-12       Impact factor: 3.550

7.  C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia.

Authors:  Eun-Hye Hur; Je-Hwan Lee; Michael Jinpyo Lee; Seong-Jun Choi; Jung-Hee Lee; Mun Jung Kang; Miee Seol; Yae Eun Jang; Hee-Jung Lee; Ip-Sol Kang; Soo-Kyung Shim; Seong-Gil Ryu; Young-Ah Kang; Young-Shin Lee; Chan-Jeoung Park; Hyun-Sook Chi; Kyoo-Hyung Lee
Journal:  Leuk Res       Date:  2008-02-12       Impact factor: 3.156
  7 in total
  1 in total

Review 1.  Systematic Review of Pharmacogenetics of ABC and SLC Transporter Genes in Acute Myeloid Leukemia.

Authors:  Juan Eduardo Megías-Vericat; David Martínez-Cuadrón; Antonio Solana-Altabella; José Luis Poveda; Pau Montesinos
Journal:  Pharmaceutics       Date:  2022-04-17       Impact factor: 6.525
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.